Drug intelligence / Profile preview

Sishen Pills

Development stage
Unknown
Administration
Oral, Rectal
01

Overview

Sishen Pills (also known as Sishen Wan) is a classic traditional Chinese medicine (TCM) patent formula widely used to treat gastrointestinal disorders, particularly chronic diarrhea, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD) such as ulcerative colitis. The formula is traditionally indicated for diarrhea associated with spleen-kidney yang deficiency. It is a multi-herb preparation typically composed of four primary botanical ingredients: Psoraleae Fructus (*Psoralea corylifolia*), Myristicae Semen (*Myristica fragrans*), Euodiae Fructus (*Evodia rutaecarpa*), and Schisandrae Chinensis Fructus (*Schisandra chinensis*), often prepared with fresh ginger (*Zingiber officinale*) and jujube (*Ziziphus jujuba*) as excipients. Sishen Pills exert their therapeutic effects through multi-component, multi-target mechanisms, including the regulation of inflammatory pathways (such as NLRP3/ASC/Caspase-1 and PI3K/Akt), reduction of oxidative stress, modulation of the immune response (restoring Treg/Th17 balance), and restoration of gut microbiota homeostasis.

Other names
Si-Shen-WanSishen PillSishen WanSishen-Wan
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)NF-κBNLRP3 (Nod-like receptor family pyrin domain-containing protein 3)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on Sishen Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sishen Pills.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call